{"log_id": 8846725483213736991, "direction": 0, "words_result_num": 47, "words_result": [{"probability": {"variance": 0.030445, "average": 0.880234, "min": 0.352256}, "location": {"width": 1215, "top": 109, "height": 63, "left": 269}, "words": "肝功能不全患者:伴发肝脏疾病的患者应域用舍林,肝功能损伤患者应减药剂或给药频"}, {"probability": {"variance": 0, "average": 0.998707, "min": 0.998707}, "location": {"width": 29, "top": 159, "height": 29, "left": 166}, "words": "率"}, {"probability": {"variance": 0.009871, "average": 0.959521, "min": 0.596177}, "location": {"width": 854, "top": 196, "height": 52, "left": 216}, "words": "8,肾功能不全患者:无需根据肾功能损害程度调整合曲林给药剂量"}, {"probability": {"variance": 0.000862, "average": 0.983899, "min": 0.890751}, "location": {"width": 328, "top": 237, "height": 45, "left": 171}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 0.020769, "average": 0.925324, "min": 0.376523}, "location": {"width": 1253, "top": 278, "height": 63, "left": 223}, "words": "曾在大鼠及家兔进行了生殖毒性研究,在人类最大用药剂量的20倍和1D(按xg/kg/日计的剂量水"}, {"probability": {"variance": 0.005863, "average": 0.958894, "min": 0.558088}, "location": {"width": 1320, "top": 317, "height": 68, "left": 159}, "words": "平下均无致畸证据。然而在相当手人类最大用约剂量的2.5倍至10倍的水平(按mkg日计),舍曲"}, {"probability": {"variance": 0.00922, "average": 0.972297, "min": 0.504879}, "location": {"width": 721, "top": 365, "height": 47, "left": 157}, "words": "林与胚胎的骨七延迟有关,可能继发对于胚胎屏障的影响"}, {"probability": {"variance": 0.018316, "average": 0.917768, "min": 0.377137}, "location": {"width": 1228, "top": 408, "height": 59, "left": 221}, "words": "在人类最大剂量约5倍的剂量水平下(按mkg/日计),给予母体含曲林后出现新生幼子存活率降低"}, {"probability": {"variance": 0.012855, "average": 0.956051, "min": 0.413796}, "location": {"width": 1210, "top": 452, "height": 54, "left": 155}, "words": "对于其它的抗抑郁药物也曾有过对于新生幼了存活率降低的描述,这些影响的临床意义还不明"}, {"probability": {"variance": 0.000604, "average": 0.989219, "min": 0.87734}, "location": {"width": 1153, "top": 495, "height": 54, "left": 212}, "words": "对于妊娠期妇女没有进行过足够的良好的对照研究。孕妇只有在利大于弊的情况下才能用药"}, {"probability": {"variance": 0.004421, "average": 0.978429, "min": 0.620925}, "location": {"width": 1256, "top": 539, "height": 54, "left": 219}, "words": "现有的关于乳汁中台曲林浓度的数据资料较为有限。对小样本量的哺乳期母亲及婴儿的零星研究提"}, {"probability": {"variance": 0.022574, "average": 0.935641, "min": 0.393895}, "location": {"width": 1322, "top": 580, "height": 57, "left": 153}, "words": "示,尽管乳汁中曲林浓度高于血清中浓度,婴儿血的舍曲林浓度极低测不到、哺乳女只有在利"}, {"probability": {"variance": 9.5e-05, "average": 0.994685, "min": 0.970843}, "location": {"width": 317, "top": 625, "height": 36, "left": 150}, "words": "大于弊的情况下才能使用"}, {"probability": {"variance": 0.009407, "average": 0.940155, "min": 0.581089}, "location": {"width": 1263, "top": 664, "height": 59, "left": 207}, "words": "妊娠和/或哺乳期服用舍曲林,医生应当注意撤药反应的症状:母亲服用包括舍曲林的5-鞋胺类抗抑"}, {"probability": {"variance": 0.007262, "average": 0.967342, "min": 0.608271}, "location": {"width": 634, "top": 712, "height": 36, "left": 150}, "words": "郁药物,新生儿出现类似撤药反应的症状已有报道"}, {"probability": {"variance": 0.001363, "average": 0.983022, "min": 0.80482}, "location": {"width": 1311, "top": 749, "height": 59, "left": 157}, "words": "【儿童用药】尽管儿童患者对舍由林的代谢稍快,为了避免产生过高的血药浓度,对儿童患者建议使用较"}, {"probability": {"variance": 0.001234, "average": 0.98289, "min": 0.866256}, "location": {"width": 516, "top": 794, "height": 36, "left": 148}, "words": "低剂量,尤其是6~12岁体重较轻的儿童"}, {"probability": {"variance": 0.00462, "average": 0.968682, "min": 0.69915}, "location": {"width": 1315, "top": 835, "height": 54, "left": 153}, "words": "【老年用药】老年患者用药剂量范围与年轻患者的相同。共700多老年患者>65岁)参加了证实舍曲林"}, {"probability": {"variance": 0.005507, "average": 0.967826, "min": 0.695327}, "location": {"width": 1158, "top": 877, "height": 52, "left": 143}, "words": "在这部分人群中疗效的临床试验。老年患者中不良反应的形式和发生率与年经患者中的相似"}, {"probability": {"variance": 0.000202, "average": 0.991169, "min": 0.956867}, "location": {"width": 210, "top": 922, "height": 34, "left": 153}, "words": "【药物相互作用"}, {"probability": {"variance": 0.016013, "average": 0.940123, "min": 0.455788}, "location": {"width": 1267, "top": 963, "height": 52, "left": 198}, "words": "单氧化酶扣制剂(MAOs);舍曲林合并单肢氧化酶抑制剂,包括选择性的单胺氧化酶抑制剂司来"}, {"probability": {"variance": 0.015873, "average": 0.955477, "min": 0.398451}, "location": {"width": 1322, "top": 1005, "height": 54, "left": 141}, "words": "吉兰和可逆性的单胺氧化酶抑制剂吗氯贝肢治疗出现了严重副应,有时是致命性的有些病例是类似5-"}, {"probability": {"variance": 0.008186, "average": 0.960012, "min": 0.537681}, "location": {"width": 1324, "top": 1048, "height": 52, "left": 137}, "words": "羟色肢综合症的表现,包括:发热、强直、肌肉痉挛、自主神经功能紊乱伴生命体征快速波动:精神状况"}, {"probability": {"variance": 0.012558, "average": 0.945137, "min": 0.527856}, "location": {"width": 1327, "top": 1091, "height": 52, "left": 137}, "words": "的改变包括精神紊乱、易激惹及极度激越直至发展为谐妄和昏迷。所以,眼月羊胺氧化酶抑制剂时或停用"}, {"probability": {"variance": 0.006545, "average": 0.962232, "min": 0.581218}, "location": {"width": 1322, "top": 1132, "height": 52, "left": 137}, "words": "单胺氧化酶抑制剂14天内不能服用舍曲林:同样,舍曲林停用片也需t4天以上才能开始单股氧化酶抑制"}, {"probability": {"variance": 1e-05, "average": 0.998091, "min": 0.99263}, "location": {"width": 114, "top": 1178, "height": 31, "left": 137}, "words": "剂的治疗"}, {"probability": {"variance": 0.006082, "average": 0.961884, "min": 0.612442}, "location": {"width": 1265, "top": 1217, "height": 57, "left": 194}, "words": "中枢神经系统抑制剂和酒精:每日同时服用舍曲林200mg不会增加乙醇、卡马西平、氟哌啶醇或苯妥"}, {"probability": {"variance": 0.009654, "average": 0.969317, "min": 0.420719}, "location": {"width": 1066, "top": 1258, "height": 52, "left": 137}, "words": "英对健康受试者认知功能和精神运动性活动能力的作用,但不张舍曲林与酒精合用"}, {"probability": {"variance": 0.002043, "average": 0.984228, "min": 0.718654}, "location": {"width": 1249, "top": 1304, "height": 50, "left": 191}, "words": "锂剂:对正常志愿者进行的安慰剂对照试验中,舍曲林与判合用未明显改变锂的药代动力学参数"}, {"probability": {"variance": 0.009308, "average": 0.968542, "min": 0.514625}, "location": {"width": 1329, "top": 1345, "height": 54, "left": 130}, "words": "但与安慰剂相比震颤增多:表明两药之间存在药效学相互作用的可能、会曲林与其经5羟色能机制起"}, {"probability": {"variance": 0.043513, "average": 0.8063, "min": 0.379096}, "location": {"width": 666, "top": 1388, "height": 68, "left": 43}, "words": "如剂合用时,应对病人进行监护"}, {"probability": {"variance": 0.031007, "average": 0.900524, "min": 0.401761}, "location": {"width": 1263, "top": 1427, "height": 57, "left": 191}, "words": "苯妥健康志愿者的安剂对照研究中,每日200mg含曲林长期服药并不显著地抑制苯妥英的代"}, {"probability": {"variance": 0.007576, "average": 0.781879, "min": 0.71743}, "location": {"width": 191, "top": 1470, "height": 98, "left": 6}, "words": "爱、有"}, {"probability": {"variance": 0.017147, "average": 0.938648, "min": 0.383265}, "location": {"width": 1329, "top": 1470, "height": 54, "left": 127}, "words": "。然与舍曲林合用,在开始加用舍曲林时应当监测苯妥英的血浓度,同时适当调整苯妥英的"}, {"probability": {"variance": 0.031283, "average": 0.814807, "min": 0.637938}, "location": {"width": 166, "top": 1525, "height": 45, "left": 173}, "words": "48"}, {"probability": {"variance": 0.037198, "average": 0.86711, "min": 0.533501}, "location": {"width": 102, "top": 1560, "height": 36, "left": 187}, "words": "舒马普坦"}, {"probability": {"variance": 0.010096, "average": 0.970581, "min": 0.379098}, "location": {"width": 1084, "top": 1557, "height": 52, "left": 354}, "words": "舍曲林上市后,有个别报道舍曲林与舒马坦合并使用后,病人出现体弱、反射亢进"}, {"probability": {"variance": 0.012893, "average": 0.951077, "min": 0.448962}, "location": {"width": 1295, "top": 1601, "height": 50, "left": 155}, "words": "济失调识模糊、焦虑和微越。如果临床上确实需要舍曲林与该药合并使用的活,应当对病人进行密"}, {"probability": {"variance": 8e-06, "average": 0.996285, "min": 0.992247}, "location": {"width": 114, "top": 1646, "height": 31, "left": 127}, "words": "切的观察"}, {"probability": {"variance": 0.009802, "average": 0.963183, "min": 0.386236}, "location": {"width": 1263, "top": 1685, "height": 52, "left": 187}, "words": "与蛋自结合的药物:舍曲林与血浆蛋白结合,应注意舍曲林和其它与血浆蛋白结合药物之间相互作"}, {"probability": {"variance": 0.00887, "average": 0.968202, "min": 0.385959}, "location": {"width": 1329, "top": 1726, "height": 52, "left": 121}, "words": "用的可能性。但是,舍曲林分别与地西泮、甲苯磺丁和华法林相互作用的三项正式研究中,未见舍曲林"}, {"probability": {"variance": 0.00337, "average": 0.984088, "min": 0.752026}, "location": {"width": 495, "top": 1772, "height": 36, "left": 121}, "words": "对这些药物的蛋白结合率有明显的影响"}, {"probability": {"variance": 0.009103, "average": 0.958882, "min": 0.494577}, "location": {"width": 1263, "top": 1813, "height": 50, "left": 185}, "words": "华法林:含曲林200mg/日与华法林联合应用在一定程度上增加凝血酶原时间,但临床意义不明确。因"}, {"probability": {"variance": 0.004616, "average": 0.975912, "min": 0.707301}, "location": {"width": 806, "top": 1859, "height": 36, "left": 121}, "words": "此,舍曲杯与华法林联合应用或停用时应密切监测凝血酶原时间"}, {"probability": {"variance": 0.010907, "average": 0.952933, "min": 0.44374}, "location": {"width": 1260, "top": 1895, "height": 52, "left": 187}, "words": "与其它药物的相互作用:已进行了舍曲林与其它药物间相互作用的研究。每日舍林200mg与地西"}, {"probability": {"variance": 0.01097, "average": 0.949787, "min": 0.584804}, "location": {"width": 1324, "top": 1939, "height": 47, "left": 118}, "words": "泮或甲苯磺丁脲合用可导致一些药代动力学参数较小的、但有统计意义的改变,与西咪替丁合用可明显降"}, {"probability": {"variance": 0.019155, "average": 0.939004, "min": 0.379168}, "location": {"width": 1311, "top": 1982, "height": 47, "left": 116}, "words": "低舍曲林的清除。这些改变的临床意义尚不清楚。舍曲林对阿替尔的β肾上腺能阻滞作用无任何影响"}], "language": 3}